SCHEMBL3516208

SCHEMBL3516208

CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)C(=O)CCl

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 11/20 0.47
▸ NPY1R P25929 6/20 0.47
▸ NPY2R P49146 4/20 0.47
▸ NPY5R Q15761 4/20 0.47
▸ FURIN P09958 5/20 0.39
▸ GNAI3 P08754 1/20 0.38
▸ GNAO1 P09471 1/20 0.38
▸ GNAI1 P63096 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ PCSK6 P29122 1/20 0.37
▸ PRSS1 P07477 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407969 0.90 NPY4R (0.45) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL30486089 0.88 NPY4R (0.49) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL4331923 0.86 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL30844259 0.86 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL30486088 0.86 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL8742594 0.86 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL31376472 0.86 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL30423395 0.86 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL29378646 0.86 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL30121066 0.86 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155894-A2 TARGETING HOST PROTEINASES AS A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL PATHOGENS Burnham Institute for Medical Research (US) 2010-02-24 — — EP disclosed
WO-2009023306-A2 TARGETING HOST PROTEINASES AS A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL PATHOGENS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-02-19 — — WO disclosed
EP-1663300-A1 INHIBITORS OF PACE4 FOR THE TREATMENT OF ARTHRITIS Pharmacia Corporation (US) 2006-06-07 — — EP disclosed
WO-2005025611-A1 INHIBITORS OF PACE4 FOR THE TREATMENT OF ARTHRITIS PHARMACIA CORPORATION (US) 2005-03-24 — — WO disclosed
Send feedback